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antiepileptic studyAbstract In the quest of ﬁnding new drug leads with potential antibacterial and antiepileptic activ-
ities, synthesis of thiazolidinone derivatives 6(a–c) is reported which are obtained from 5-(4-chloro-
benzylidine)-3-[4-(7-chloroquinoline-4-ylamino]propyl)-2-imino-thiazolidin-4-one derivatives by
applying appropriate synthetic route. These compounds 6(a–c) were evaluated for antibacterial
and antiepileptic activities. Compound 6a having good lipophilicity is found to be most active.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Thiazolidinone derivatives are the subject of renowned interest
because they have been found to be useful intermediates for
the synthesis of various heterocyclic compounds (Singh
et al., 1981). The most important results of extensive studies
(synthesis, spectral, structural characterization and applica-
tions in various biological systems) of thiazolidinone deriva-
tives are reviewed (Metzger et al., 1984). Thiazolidinone
derivatives are associated with multifarious biological activities
such as analgesic (Hosni and Abdulla (2008), anti-inﬂamma-
tory (Vigorita et al., 2001), antimicrobial (Sharma and Jain
(2008), tuberculo-static, hormone receptor (Pelletier et al.(2005), CNS stimulant (Chaudhary et al. (1976), antiprolifera-
tive (Ottana et al. (2005), anti-HIV Monforte et al. (2001), Ali
et al. (2007), anticonvulsant Gursoy and Terzioglu (2005),
antihistaminic Vittoria et al. (1992), etc.
Epilepsy is a neurological disorder characterized by unpro-
voked seizures, and affects at least 50 million people world-
wide. There is a continuing demand for new anticonvulsant
agents as it has not been possible to control every kind of sei-
zure with the currently available antiepileptic drugs. Phenobar-
bital and mephobarbital are well-known barbituric acid
derivatives which are used for the treatment of epilepsy. These
drugs are very effective in controlling the seizures but they suf-
fer from major side effects such as sedation, and hypnosis. So
there is an urge for the development of effective anticonvulsant
drugs with less or no side effects. Ralitoline (Fig. 1) is one of
the compounds which possesses a thiazolidinone moiety and
found to be effective in preclinical anticonvulsant models.
Based on these literature evidences we thought to synthesize
some thiazolidinone derivatives having anticonvulsant activity.
These compounds were obtained from 5-(4-chlorobenzylidene)-
Cl
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Figure 1 Ralitoline.
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4-one derivatives 5(a–c), following the synthetic strategy as
shown in Scheme 1. The structure of the newly synthesized
compounds is proved using spectroscopic methods such as IR,
1HNMR and mass spectral data.
2. Experimental
The entire chemicals were purchased from Aldrich Chemical
Company (USA) and were used after puriﬁcation by distilla-
tion. The reactions were monitored by precoated aluminum sil-
ica gel 60F 254 thin layer plates procured from Merck
(Germany). All melting points were measured by a capillary
apparatus and are uncorrected. All the compounds were rou-
tinely checked by IR, 1H-NMR and mass spectrometries. IR
spectra were recorded in KBr on a Perkin–Elmer model 8201
FTIR spectrophotometer. 1H-NMR spectra were recorded
at ambient temperature using a Brucker spectroscopin
DPX-300 MHz spectrophotometer in DMSO. The following
abbreviations were used to indicate the peak multiplicity as s
– singlet, d – doublet, t – triplet, and m – multiplet. FAB mass
spectra were recorded on a JEOL SX102 mass spectrometer
using Argon/Xenon (6 kV, 10 mB) gas. Column chromatogra-N
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Schemephy was performed on silica gel (Merck). Anhydrous sodium
sulfate was used as a drying agent for the organic phase.
2.1. Synthesis of N-(7-chloroquinolin-4-yl) propane 1, 2-diamine
(2)
A mixture of 4-7-dichloroquinoline (2.97 g, 0.59 mol) and 1-2-
diaminopropane (0.89 g, 0.07 mol) in ethanol was reﬂuxed
with stirring for 8 h. It was cooled and distilled in the solvent.
Solid product was dissolved in DCM (80 ml), washed with 5%
of sodium bicarbonate and brine solution. The organic layer
was ﬁltered and dried over Na2SO4. The solid product was
recrystallized from EtOH to give compound 2 (yield 55%)
m.p. 97–98 C. IR (KBr) cm1 3272 [NH str.], 2928[C–H str.
Ar. H], 1552 [C–N str.], 815 [C–Cl str.], 1485 [C–H bend.
CH2], 1197 [C–C str.].
1H-NMR (CDCl3) d 8.64(d, 1H, CH),
8.5(s, 1H,CH), 8.3 (m, 2H,CH), 7.43 (q, NH), 6.49 (d,
1H,CH), 4.12(s,1H, NH) 2.0 (t,2H, CH), 1.7 (q, 2H,CH).
MS: [m/z] 235.71 (M+1) Anal. Calculated/found for
C8H14ClN3: C, 16.59/16.04; N, 19.83/19.06.
2.2. Synthesis of N-(7-chloroquinolin-4-yl) propane 1, 2-diamine
(2) [microwave method]
A mixture of 4-7-dichloroquinoline (2.97 g, 0.59 mol) and 1-2-
diaminopropane (0.89 g, 0.07 mol) in ethanol was placed in a
100 ml borosil ﬂask ice ﬁtted with a funnel as a loose top.
The reaction mixture was subjected to microwave irradiation,
at 20% (360 W) for 10 min. Completion of reaction was
checked by TLC and UV. The reaction mixture was cooled
and the resulting solid was ﬁltered, washed with ethanol, dried
and recrystallized from ethanol to give compound 2 (yield
40.45%).H 2)3NH2
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S18 J. Dwivedi et al.2.3. Synthesis of 2-chloro-N-(2-(7-chloroquinoline-4-
ylamino)propyl) chloroacetanilides (3)
Compound N-(7-chloroquinoline-4-yl) propane-1, 2-diamine
(2) (2.35 g, 10 mmol), triethyl amine (1 ml, 1.01 mmol) and
chloroacetyl chloride (0.75 ml, 10 mmol) were dissolved in
dry ethanol (25 ml). The mixture was stirred for 30 min on
ice bath then reﬂuxed with stirring for 4–6 h. Reaction mixture
was cooled and solvent was evaporated. Now, the solid prod-
uct was dissolved in DCM and water. The organic layer was
ﬁltered and dried over Na2SO4. The solid product was recrys-
tallized from EtOH to give compound 3 (yield 40%), m.p. 102–
104 C. IR (KBr) cm1 3419 [NH str.], 3008[C–H str. Ar. H],
1200 [C–N str.], 1002 [C–Cl str.], 3352 [C–C str.]. 1H-NMR
(CDCl3) d 8.9(d, 1H,CH), 8.7 (d, 1H,CH), 8.3 (m, 2H,CH),
8.0 (m,NH), 7.4 (q,NH), 6.49 (d, 1H,CH), 2.5 (s,1H, NH)
2.08 (t,2H, CH), 1.7 (q, 2H,CH). MS: [m/z] 235.71 (M+1)
Anal. Calculated/found for C14H15Cl2N3O: C, 12.84/12.04;
N, 55.06/54.92.
2.4. Synthesis of 3-(2-(7-chloroquinoline-4-ylamino)propyl)-2-
iminothiazolidi-4-one (4)
Compound 2-chloro-N-(2-(7-chloroquinoline-4-ylamino)pro-
pyl) chloroacetanilides (3) (0.78 g,2.5 mmol) and potassium
thiocyanate (0.78 g, 1.1 mmol) were mixed in dry acetone fol-
lowed by reﬂuxing on water bath for about 8 h. Progress of
reaction was checked by TLC. Reaction mixture was cooled
and solvent was evaporated. Now, the solid product was dis-
solved in DCM and water. The organic layer was ﬁltered
and dried over Na2SO4. The solid product was recrystallized
from EtOH to give compound 3 (yield 45%), m.p. 150–151 C.
2.5. Synthesis of 5-(4-chlorobenzylidene)-3-[4-(7-
chloroquinoline-4-ylamino] propyl)-2-imino- thiazolidin-4-one
(5a)
A mixture of 3-(2-(7-chloroquinoline-4-ylamino)propyl) -2-
iminothiazolidi-4-one (4) (0.78 g, 2.5 mmol) and p-chloro
benzaldehyde (0.78 g, 1.1 mmol) was dissolved in dry benzene
and reﬂuxed for about 8 h. After completion of reaction, it was
cooled. After evaporation of the solvent yielded a solid prod-
uct which was puriﬁed over the column of silica gel and eluted
with ethanol to give compound 5a (yield 65%), m.p. 125-126Table 1 Antiepileptic activity of synthesized spirothia-zolidinone
seizure in mice.
Time duration (s)
Treatment Tonic ﬂexion
(mean ± SEM)
Ton
(me
Control 245 ± 1.80 170
Diazepam 4 mg/kg 3.6 ± 6.1* 05
Comp (6a) 100 mg/kg
propane
40.3 ± 5.7* 30.
Comp II (6b) 100 mg/kg
propane
120.2 ± 4.7* 80
Comp III (6c) 100 mg/
kg propane
150.3 ± 5.7* 120
* P< 0.05, compared with control, No. of animals (n= 6) in each grouC. IR (KBr) cm1 3200 [NH str.], 3124[C–H str. Ar. H],
1209 [C–N str.], 1022 [C–Cl str.], 3002 [C–C str.], 1144 and
690 (C–S of thiazolidinone ring). 1H-NMR (CDCl3) d 8.9 (s,
1H,NH), 8.7(d, 1H,CH) 8.3 (d, 1H,CH), 8.1 (m, 4H,CH), 7.8
(s,NH), 7.4 (d,1H), 6.49 (d, 1H,CH), 3.3 (d,2H, CH) 2.5
(d,2H, CH), 1.6(m, 6H,CH).
2.6. Synthesis of 5-(4-chlorobenzylidene)-3-[4-(7-
chloroquinoline-4-ylamino] propyl)-2-imino- thiazolidin-4-one
(5a) [microwave method]
A mixture of 3-(2-(7-chloroquinoline-4-ylamino)propyl) -2-
iminothiazolidi-4-one (4) (0.78 g, 2.5 mmol) and p-chloro
benzaldehyde (0.78 g, 1.1 mmol) dissolved in dry benzene
was placed in a 100 ml borosil ﬂask ice ﬁtted with a funnel
as a loose top. Reaction mixture was subjected to microwave
irradiation at 360 W for 15 min. Completion of reaction was
checked by TLC and UV. After cooling the reaction mixture
a solid was obtained which was recrystallized from ethanol
to give compound 5a.
2.7. Synthesis of 2-(4-chlorobenzylidene)-4-(2[7-
chloroquinolin-4-ylamine]propyl) 1,6-dithia-4,9-
diazaspiro[4,4]nonane-3,8-dione (6a)
A mixture of compound 5a (0.18 g, 0.429 mol) and thioglycolic
acid (0.276 g, 0.03 mol) was dissolved in dry benzene and
reﬂuxed on water bath for 24 h. After completion of reaction
it was cooled and neutralized with an aqueous solution of so-
dium bicarbonate. The organic layer was separated followed
by evaporation. Resultant solid was puriﬁed over the column
of silica gel and eluted with ethanol to give compound 6a
(Yield 60%), m.p. 165–166 C. IR (KBr) cm1 3407 [NH
str.], 3359 [C–H str. Ar. H], 1313 [C–N str.], 1035 [C–Cl
str.], 3002 [C–C str.], 1708 [C‚O], 1144 and 690 (C–S of thia-
zolidinone ring). 1H-NMR (CDCl3) d 8.3(d, 1H,), 8.1(d,
1H,CH), 7.8 (d, 1H,CH), 7.4 (m, 4H,CH), 6.49 (d,
1H,CH),4.4 (s, 1H, NH), 3.3 (t,2H, CH) 2.3 (d,2H, CH), 1.3
(m, 6H,CH).
3. Antiepileptic activity
Male Wistar albino mice having weight 80–130 g were kept in
quarantine for 10 days under standard husbandry conditionsderivatives using maximal electroshock seizure (MES) induced
ic extension
an ± SEM)
Clonic stupor
(mean ± SEM)
Mortality
(mean ± SEM)
± 4.90 200 ± 4.9* 100
± 1.9* 03 ± 1.73* 00
0 ± 4.8* 32 ± 5.5* 20.2
± 5.3* 60.6 ± 5.5* 22.00
± 5.3* 127.6 ± 5.3* 24.2
p.
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light cycles respectively and were given standard food and
water ad. libitum. The project proposal was approved by the
Institutional Animal Ethics Committee (ref. no. PBRI/11/
IAEC/223). The outcome of this study is presented in Table 1.
3.1. Acute oral toxicity study
Acute oral toxicity test was performed for substituted [spiro-4-
thiazolidinone] 6(a–c) compounds following the OECD guide-
line – 420. Starting with the least dose of these synthesized
compounds 6(a–c) increasing doses, up to 2000 mg/kg body
weight, were administered to different groups of mice and their
mortality was determined. (Fisher, 1989). Substituted [spiro-4-
thiazolidinone] 6(a–c) were screened for their antiepileptic
potential using maximum electroshock (MES) induced seizure.
(Ecobichon, 1997).
3.2. Experimental setup
The animals were divided into 5 groups of 6 numbers each and
were administered as follows:Table 2 Antimicrobial activities of the synthesized compounds 3, 5
Showing maximum activity.
Showing minimum activity.Group I received vehicle
Group II received Diazepam 4 mg/kg
Group III received Compound 6(a)30 mg/kg suspended in
Tween 80
Group IV received Compound 6(b) 30 mg/kg suspended in
Tween 80
Group V received Compound 6(c) 30 mg/kg suspended in
Tween 80
Diazepam (4 mg/kg) was used as reference standard. All
these compounds were administered by intraperitoneal route
(i.p.) 30 min before application of electroshock (42 MA,
0.2 s) using corneal electrode. The mice were observed for
the reduction in duration of tonic ﬂexion, extension and clonic
stupor convulsions.
4. Antimicrobial activity
The in vitro antimicrobial activity of compounds 5a, 5b, 5c and
6a, 6b, 6c was performed using the disk diffusion method
(Hassan et al. (1998), Patel and Trivedi (1977). Ciproﬂoxacin
for bacteria and ﬂuconazole for fungal were used as standard(a–c), 6(a–c).
S20 J. Dwivedi et al.drugs. The compounds 5a, 5b, 5c and 6a, 6b, 6c were
tested for their anti-bacterial and anti-fungal activities by
disk-diffusion method using nutrient broth medium [contained
(g/l): beef extract 3 g; peptone 5 g; pH 7.0] for bacteria and
potato dextrose broth medium [contained (g/l): beef extract
3 g; peptone 5 g; pH 7.0] for fungi. The Gram-positive bacteria
and Gram-negative bacteria utilized in this study consisted of
E. coli, and B. subtilis for bacterial species and A. niger and
A. ﬂavus for the fungal species. In the disk-diffusion method,
sterile paper disks (0.5 mm) impregnated with compound
dissolved in dimethylsulfoxide (DMSO) at concentrations
100, 200 and 400 lg/ml were used. Then, the paper disks
impregnated with the solution of the tested compounds were
placed on the surface of the media inoculated with the micro-
organism. The plates were incubated at 35 C for 24 h. After
incubation, the growth inhibition zones and activity were
checked out. The outcome of this study is presented in Table 2.
5. Results and discussion
A rapid simple and efﬁcient method has been developed for the
synthesis of some novel benzylidene spiro thiazolidinone deriv-
atives under conventional and microwave conditions. The thia-
zolidinone derivatives were synthesized and evaluated for their
physical, analytical and spectral data. Characteristic IR bands
provide signiﬁcant indications for the formation of thiazolidi-
none derivatives. IR spectra of all the compounds showed
1500–1578 cm1 (NH str.), 1735–1770 cm1 (C‚O str.),
1600–1475 cm1(C‚C str.), 1144 and 690 (C–S of thiazolidi-
none ring), which conﬁrmed the formation of thiazolidinone
derivatives. Structures of thiazolidinone derivatives were fur-
ther conﬁrmed by 1H-NMR spectra, which proved as a diag-
nostic tool for the positional elucidation of the proton.
Assignments of the signals are based on chemical shift and
intensity pattern. The 1H-NMR spectra showed multiplates
in the region 1.5–2.0 ppm for (CH2) and doublets in the region
8.14–7.3 ppm for aromatic proton in all spectra respectively.
Characteristic peaks were observed in the mass spectra of all
compounds which followed the similar fragmentation pattern.
The spectra of compounds showed molecular ion peak (M+)
at m/z which conﬁrmed the molecular weight of the thiazolid-
inone derivatives.
The synthesized compounds 3, 5(a–c) and 6(a–c) were
screened for antibacterial activity against two pathogenic strains
(E. coli andB. subtilis).The antibacterial screening againstE. coli
showed that among the compounds 3, 5(a–c) and 6(a–c) the
compound 6a displayed highest activity. Contrary to this
observation, compound 5a showed highest activity among all
the compounds screened for this activity against B. subtilus.
Similarly the antifungal activity was evaluated against two
pathogenic strains (A. niger and A. ﬂavus). The zone of inhibi-
tion and activity index were determined by comparison with
the standard drug ﬂucanazole. The compound 6a displayed
highest activity against A. niger. Contrary to this observation,
compounds 3 and 6b showed highest activity among all the
compounds screened for this activity against A.ﬂavus.All the compounds 6a–c were tested for their antiepileptic
activities using maximum electro seizure method and results
are shown in Table 1. Diazepam (4 mg/kg) was used as stan-
dard for this study. The tonic ﬂexion and extension along with
clonic stupor was observed for control synthesized compound
and standard and 6a was found to be more potential among all
the derivatives tested. The probable cause of potentiality of 6a
is due to greater lipophilicity of chloro group which in turn is
responsible for greater penetrability of the compound in the
cell.
In conclusion, the present study throws light on the identi-
ﬁcation of this structural class as antiepileptic agent which can
be of interest for further detailed preclinical investigations.Acknowledgements
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